MAM
Media2win bags UTV Motion Pictures’ digital mandate
MUMBAI: The full service agency Media2win has won the digital account of UTV Motion Pictures following multi agency pitch.
Media2win will be responsible for handling the creative ideas, social media, digital media planning and buying, search, mobile and other innovative solutions for the film production house.
UTV Motion Pictures Sr VP marketing Shikha Kapur said, “Going forward, we see the digital space as one of the most important mediums to market our movies. The interactivity that the digital medium offers is a superb opportunity for us to engage our audience right from the very beginning of a film campaign.”
Further she added that Media2win impressed the company with their analytical approach to the business. “What clinched the deal for Media2win was that this analysis didn‘t compromise the creativity that our product requires, especially in the dynamic nature of the digital domain,” concluded Kapur.
Media2win COO Namrata Balwani added, “The investment into movie marketing on the digital media has grown tremendously in India. The rise of social media and sharing oriented behaviour provides a great opportunity to think creatively.”
MAM
Beacon Group appoints Dr Rajesh Patel as Group CEO
36-year healthcare veteran to lead Beacon Diagnostics, Vector Biotek, Biogeny.
MUMBAI: A new chief, a fresh diagnosis and a sharper prescription for growth. Beacon Group has appointed Dr Rajesh Patel as its Group Chief Executive Officer, effective April 1, 2026, signalling a decisive push to scale its presence in the diagnostics and IVD space. Patel steps into the role with 36 years of experience across the healthcare and diagnostics industry, bringing a career shaped by leadership roles spanning sales, marketing, business development and operational strategy. His mandate is both expansive and precise: to steer the group’s overall strategic direction while tightening coordination across its three core entities Beacon Diagnostics, Vector Biotek and Biogeny Diagnostics.
In practical terms, that means driving cross-company synergies, accelerating market expansion and strengthening organisational capability areas increasingly critical as diagnostic players compete for scale in a fragmented yet rapidly evolving healthcare ecosystem. The group is positioning itself to capture unmet demand across chain laboratories, key accounts and standalone labs, segments that remain underserved despite growing diagnostic needs.
The appointment comes at a time when the In Vitro Diagnostics (IVD) sector in India is entering a more competitive and innovation-led phase, with companies focusing not just on product pipelines but also on service delivery, integration and customer-centric models. Beacon’s leadership appears to be betting that Patel’s execution-focused approach can help translate ambition into operational momentum.
Welcoming the appointment, Chairman Dr D K Joshi described Patel’s induction as a strategic move aligned with the group’s long-term vision, emphasising the role of leadership depth in navigating the next phase of growth.
For Beacon Group, the message is clear, in a sector where precision matters, leadership is the new differentiator—and this appointment is intended to set the tone for what comes next.
